Ignite Creation Date:
2024-05-06 @ 7:05 PM
Last Modification Date:
2024-10-26 @ 3:00 PM
Study NCT ID:
NCT05891548
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-11-02
First Post:
2023-05-24
Brief Title:
Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration
Sponsor:
Clearside Biomedical Inc
Organization:
Clearside Biomedical Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-31
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-07
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-24
First Submit QC Date:
June 4 2023
Study First Post Date:
2023-06-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-01
Last Update Post Date:
2023-11-02
Last Update Post Date Type:
ACTUAL